PLIANT THERAPEUTICS, INC. — Form 8-K
Filed July 13, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 7/13/2026 disclosing Item 5.02 (officer/director departure and compensatory arrangements) for period ending 7/9/2026. Specific names, dollar amounts, titles, and arrangement details are not visible in the filing header metadata provided.
Why this rating
Leadership change is material event, but absence of concrete details (counterparty, amounts, terms) prevents full assessment. For $69.5M company, impact depends on officer seniority and severance magnitude—unknowable here.
Extracted items
See more from July 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.